GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CS Medica AS (STU:8G8) » Definitions » Cash Conversion Cycle

CS Medica AS (STU:8G8) Cash Conversion Cycle : -222.46 (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CS Medica AS Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

CS Medica AS's Days Sales Outstanding for the three months ended in Sep. 2024 was 73.05.
CS Medica AS's Days Inventory for the three months ended in Sep. 2024 was 45.48.
CS Medica AS's Days Payable for the three months ended in Sep. 2024 was 340.99.
Therefore, CS Medica AS's Cash Conversion Cycle (CCC) for the three months ended in Sep. 2024 was -222.46.


CS Medica AS Cash Conversion Cycle Historical Data

The historical data trend for CS Medica AS's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CS Medica AS Cash Conversion Cycle Chart

CS Medica AS Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cash Conversion Cycle
Get a 7-Day Free Trial 138.32 262.69 167.39 -1,203.48 -222.86

CS Medica AS Quarterly Data
Sep19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,008.97 -89.35 -222.03 -1,150.75 -222.46

Competitive Comparison of CS Medica AS's Cash Conversion Cycle

For the Medical Devices subindustry, CS Medica AS's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CS Medica AS's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CS Medica AS's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where CS Medica AS's Cash Conversion Cycle falls into.


;
;

CS Medica AS Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

CS Medica AS's Cash Conversion Cycle for the fiscal year that ended in Sep. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=136.19+127.36-486.41
=-222.86

CS Medica AS's Cash Conversion Cycle for the quarter that ended in Sep. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=73.05+45.48-340.99
=-222.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CS Medica AS  (STU:8G8) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


CS Medica AS Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of CS Medica AS's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


CS Medica AS Business Description

Traded in Other Exchanges
N/A
Address
Indiakaj 10, Copenhagen, DNK, 2100
CS Medica AS is engaged in developing, manufacturing, and commercializing over-the-counter medical device products containing cannabinoids currently focusing on cannabidiol for the treatment of psoriasis and arthritis. It operates in two business segments such as GalaxaPharma A/S responsible for distribution operation for marketing and sales direct-to-consumer, to retailers, and e-tail and CANNORDIC A/S is engaged in research and development, establishing of global business contracts, supply of CBD ingredients and production of finished products.

CS Medica AS Headlines

No Headlines